These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9019636)

  • 1. [Ovulation induction in women in the in vitro fertilization program].
    Vuleta D; Begenisić M
    Med Pregl; 1996; 49(11-12):497-500. PubMed ID: 9019636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of various factors on in vitro fertilization (IVF) and embryo transfer in the human in clomiphene/hMG/hCG stimulated cycles].
    Baukloh V; Riedel HH; Paul S; Semm K; Mettler L
    Zentralbl Gynakol; 1985; 107(23):1409-23. PubMed ID: 3938148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The hormonal micromilieu and oocyte status in the stimulated in vitro fertilization cycle].
    Sudik R; Fliess FR; Kunkel S; Blödow G
    Zentralbl Gynakol; 1989; 111(9):587-603. PubMed ID: 2500796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fertilization in vitro: ovulation induction and oocyte harvest].
    Barrière P; Lopès P
    Rev Prat; 1990 Dec; 40(29):2689-93. PubMed ID: 2281275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial.
    Serafini P; Yadid I; Motta EL; Alegretti JR; Fioravanti J; Coslovsky M
    Fertil Steril; 2006 Oct; 86(4):830-8. PubMed ID: 16963040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo maturation of oocytes by extending the interval between human chorionic gonadotropin administration and oocyte retrieval.
    Raziel A; Schachter M; Strassburger D; Kasterstein E; Ron-El R; Friedler S
    Fertil Steril; 2006 Sep; 86(3):583-7. PubMed ID: 16828475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A preliminary study on in vitro fertilization and embryo transfer].
    Chen DX
    Zhonghua Fu Chan Ke Za Zhi; 1989 Nov; 24(6):348-50, 381. PubMed ID: 2632167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of follicular fluid analysis in assessment of the main criteria of folliculogenesis in IVF program].
    Tsagareishvili GG
    Georgian Med News; 2005 Feb; (119):18-23. PubMed ID: 15834173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The beneficial effects of short-term administration of a LHRH agonist (buserelin) in in vitro fertilization].
    Loumaye E; de Cooman S; Psalti I; Schrurs B; Adam T; Depreester S; Thomas K
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(8):1081-7. PubMed ID: 3148649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luteinizing hormone-releasing hormone agonists for ovarian stimulation in assisted reproduction.
    Tan SL
    Curr Opin Obstet Gynecol; 1994 Apr; 6(2):166-72. PubMed ID: 8193257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer.
    Propst AM; Bates GW; Robinson RD; Arthur NJ; Martin JE; Neal GS
    Fertil Steril; 2006 Jul; 86(1):58-63. PubMed ID: 16753156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovulation induction for assisted reproduction.
    Scott RT; Rosenwaks Z
    J Reprod Med; 1989 Jan; 34(1 Suppl):108-14. PubMed ID: 2497245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of different ovarian stimulation protocols for in vitro fertilization.
    Pados G; Tarlatzis BC; Bontis J; Lagos S; Papadimas J; Spanos E; Mantalenakis S
    Gynecol Endocrinol; 1995 Jun; 9(2):103-12. PubMed ID: 7502685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of withholding gonadotropin (a coasting period) on the outcome of in vitro fertilization cycles.
    Owj M; Tehrani Nejad ESh; Amirchaghmaghi E; Ezabadi Z; Baghestani AR
    Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):81-5. PubMed ID: 17229513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro fertilization and embryo transfer: a brief overview.
    DeCherney AH
    Yale J Biol Med; 1986; 59(4):409-14. PubMed ID: 3532577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obstetric implications for and identification of women with a normal clomiphene citrate challenge test result who have a poor response to gonadotropins.
    Hofmann GE; Sosnowski J; Khoury J; Kearns L; Thie J
    Fertil Steril; 2004 Oct; 82(4):908-12. PubMed ID: 15482767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite responses to the addition of leuprolide acetate to human menopausal gonadotropin therapy in two perimenopausal women.
    Check JH; Adelson HG
    Int J Fertil; 1990; 35(6):343-6. PubMed ID: 1981209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
    Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with three or less dominant follicles may not be associated with reduced pregnancy rate of in vitro fertilization treatment.
    Ng EH; Yeung WS; Ho PC
    Eur J Obstet Gynecol Reprod Biol; 2006 Nov; 129(1):54-9. PubMed ID: 16584831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term utilization of a gonadotropin-releasing hormone agonist (buserelin) for induction of ovulation in an in vitro fertilization program.
    Loumaye E; de Cooman S; Anoma M; Psalti I; Depreester S; Schmit M; Thomas K
    Ann N Y Acad Sci; 1988; 541():96-102. PubMed ID: 3143299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.